NuCapCure Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.
- Coordinator
- Universitetet I Oslo, Norway
- Runs
- 1 February 2024 to 31 July 2028
- Status
- Running
- EU funding
- €6.0m
- Total cost
- €6.0m
- Partners
- 8 organisations in 6 countries
- Type
- European Innovation Council
- Grant agreement
- 101130209
What the project is doing
In the project's own words, from its summary on CORDIS.
Deep-lying cancers, such as glioblastoma multiforme (GBM) brain cancer, are very difficult to access and incurable by the current standards of care. The fluorescence of photosensitive molecules (PSs) can precisely guide surgical resection of GBM. Nevertheless, photomedical treatments like photodynamic therapy (PDT) show limited efficacies due to the low penetration of light into tissue. Proton radiotherapy can reach deep-lying disease through therapeutic energy deposition in a spatially confined region called Bragg peak.
Current neutron-based therapies, like Boron Neutron Capture Therapy (BNCT), have sufficient penetration depth but lack cancer specificity. In NuCapCure, we propose to 'hijack' intracellular biosynthetic pathways and use them to produce custom-made drugs that will facilitate two genuinely new cancer treatments: i) ""NuCapCure Proton"", combining proton radiotherapy, protondynamic therapy through PS proton activation, and proton capture therapy (BPCT) through three produced alpha particles
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitetet I Oslo | Oslo | Norway | Coordinator |
| Centrum Vyzkumu Rez Sro | Husinec-Rez | Czechia | Participant |
| Univerzita Karlova | Praha 1 | Czechia | Participant |
| Eurice European Research and Project Office GmbH | St Ingbert | Germany | Participant |
| National Center for Scientific Research ""demokritos"""" | Agia Paraskevi | Greece | Participant |
| Galchimia SA | Touro A Coruna | Spain | Participant |
| Academisch Ziekenhuis Groningen | Groningen | Netherlands | Participant |
| Oslo Universitetssykehus Hf | Oslo | Norway | Third party |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI